5-Fluorouracil was rationally designed to target thymidylate synthase (TS), an enzyme that is essential for DNA synthesis and cell proliferation; however, the biochemical mechanisms responsible for its antitumour properties are complex and actually require anabolism of this prodrug into specific 5-FU nucleotides within cancer cells. Here, TYMS is linked to cancer.